Clinical Response and Safety of Alternating Daily Dosage of Crizotinib Due to Side Effects in Advanced NSCLC Patient Harboring ROS1-Rearrangement: A Case Report. J Respirol Indones 2023, 43 (2), 111-115. https://doi.org/10.36497/jri.v43i2.201.